Alyeska Investment Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $8.91M | Sell |
|
|||||
2023
Q3 | $17.6M | Buy |
|
|||||
2023
Q2 | $25.7M | Buy |
|
|||||
2023
Q1 | $12.6M | Buy |
|
|||||
2022
Q4 | – | Sell |
|
|||||
2022
Q3 | $4.06M | Buy |
|
|||||
2022
Q1 | – | Sell |
|
|||||
2021
Q4 | $3.56M | Sell |
|
|||||
2021
Q3 | $10.1M | Sell |
|
|||||
2021
Q2 | $25.6M | Buy |
|
|||||
2021
Q1 | $10.8M | Sell |
|
|||||
2020
Q4 | $22M | Sell |
|
|||||
2020
Q3 | $14.8M | Buy |
|
|||||
2019
Q4 | – | Sell |
|
|||||
2019
Q3 | $6.61M | Sell |
|
|||||
2019
Q2 | $7.99M | Sell |
|
|||||
2019
Q1 | $14.1M | Sell |
|
|||||
2018
Q4 | $32.9M | Buy |
|
|||||
2017
Q3 | – | Sell |
|
|||||
2017
Q2 | $2.14M | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $1.88M | Buy |
|